Cardiothoracic & vascular anesthesia

Hemodynamic and Perioperative Effects of Remimazolam Versus Propofol in Adult Cardiac Surgery: A Grade-Assessed Systematic Review and Meta-Analysis

J Cardiothorac Vasc AnesthPublished Systematic review and meta-analysis of randomized controlled trials (RCTs) and comparative cohort studies

Pooled result · Intraoperative hypotensive eventsResult — go to the resultRelative risk 0.50 95% CI 0.31–0.80

Authors' conclusion

Remimazolam may provide superior hemodynamic stability and faster postoperative recovery compared with propofol in adult cardiac surgery without compromising anesthetic efficacy or safety.

Study context

Population
Adults undergoing cardiac surgery
Participants
903 adults · 9 studies
Comparison
Remimazolam vs propofol
Outcome
Study-defined hypotensive events, MAP, heart rate, BIS and operative time
Methodological detailsPRISMA-compliant, random-effects, GRADE-assessed, Evidence certainty ranged from high to low, mainly due to heterogeneity and imprecision
  • PRISMA-compliant
  • Random-effects
  • GRADE-assessed
  • Evidence certainty ranged from high to low, mainly due to heterogeneity and imprecision

Pooled result

Intraoperative hypotensive events

Relative risk

0.50

95% CI 0.31–0.80

Remimazolam vs Propofol
RR 0.50 (95% CI 0.31–0.80)

As reported in the abstract

Further pooled results

Emergence (times to eye opening and extubation)

Faster emergence with remimazolam, incl. shorter times to eye opening and extubation

Hospital LOS

No significant difference

Safety

PONV, delirium

No significant differences

Postoperative adverse events

Reduced with remimazolam

Original publication

Hemodynamic and Perioperative Effects of Remimazolam Versus Propofol in Adult Cardiac Surgery: A Grade-Assessed Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth. Published 7 July 2026. doi:10.1053/j.jvca.2026.07.006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.